HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Picornaviridae Infections

Virus diseases caused by the PICORNAVIRIDAE.
Also Known As:
Infections, Picornaviridae; Infections, Picornavirus; Infection, Picornaviridae; Infection, Picornavirus; Picornaviridae Infection; Picornavirus Infection; Picornavirus Infections
Networked: 82 relevant articles (4 outcomes, 6 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Infections
2. Virus Diseases (Viral Diseases)
3. Inflammation (Inflammations)
4. Enterovirus Infections
5. Porcine Reproductive and Respiratory Syndrome (PRRS)

Experts

1. Semler, Bert L: 7 articles (01/2020 - 09/2007)
2. van Kuppeveld, Frank J M: 3 articles (10/2014 - 01/2010)
3. Wang, Congcong: 2 articles (10/2021 - 01/2020)
4. Zhang, Xiangle: 2 articles (10/2021 - 01/2020)
5. Zheng, Haixue: 2 articles (10/2021 - 01/2020)
6. Zhu, Zixiang: 2 articles (10/2021 - 01/2020)
7. Doty, Daniel J: 2 articles (01/2021 - 01/2016)
8. Fujinami, Robert S: 2 articles (01/2021 - 01/2016)
9. Hanak, Tyler J: 2 articles (01/2021 - 01/2016)
10. Libbey, Jane E: 2 articles (01/2021 - 01/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Picornaviridae Infections:
1. Antiviral Agents (Antivirals)IBA
2. Proteins (Proteins, Gene)FDA Link
3. AntibodiesIBA
4. Neutralizing AntibodiesIBA
5. RNA (Ribonucleic Acid)IBA
6. pleconarilIBA
02/17/2012 - "Pleconaril is a novel antiviral drug being developed by Schering-Plough to treat Picornaviridae infections, and is in its late clinical trials stage. "
04/01/2002 - "This includes, for the treatment of HIV infections, virus adsorption inhibitors (cosalane derivatives, cyanovirin-N), co-receptor antagonists (TAK-779, AMD3100), viral fusion inhibitors (pentafuside T-20, betulinic acid derivatives), viral uncoating inhibitors (azodicarbonamide), nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs: emtricitabine, amdoxovir, dOTC, d4TMP prodrugs, tenofovir disoproxil fumarate), non-nucleoside reverse transcriptase inhibitors (NNRTIs: thiocarboxanilide UC-781, capravirine, SJ-3366, DPC 083, TMC 125/R165335), integrase inhibitors (diketo acids), transcription inhibitors (temacrazine, flavopiridol), protease inhibitors (atazanavir, mozenavir, tipranavir); for the treatment of RSV and paramyxovirus infections, viral fusion inhibitors (R170591, VP-14637, NMS03); for the treatment of picornavirus infections, viral uncoating inhibitors (pleconaril); for the treatment of pesti- (hepaci-, flavi-) virus infections, RNA replicase inhibitors (VP-32947); for the treatment of herpesvirus (HSV, VZV, CMV) infections, DNA polymerase inhibitors (A-5021, L- and D-cyclohexenylguanine); for the treatment of VZV infections, bicyclic furopyrimidine analogues; for the treatment of CMV infections, fomivirsen; for the treatment of DNA virus infections at large (papilloma-, polyoma-, herpes-, adeno- and poxvirus infections), cidofovir; for the treatment of influenza, neuraminidase inhibitors (zanamivir, oseltamivir, RWJ-270201); for the treatment of HBV infections, adefovir dipivoxil; for the treatment of HBV and HCV infections, N-glycosylation inhibitors (N-nonyl-deoxynojirimycin); and, finally, IMP dehydrogenase inhibitors and S-adenosylhomocysteine hydrolase inhibitors, for the treatment of various virus infections, including hemorrhagic fever virus infections."
7. MicroRNAs (MicroRNA)IBA
8. RNA-Binding Proteins (RNA-Binding Protein)IBA
9. tyrosyl-DNA phosphodiesteraseIBA
10. Viral RNAIBA

Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)